SCHEMBL7953209

SCHEMBL7953209

Cc1c(CC(N)=O)c2ccc(OCCCC(=O)O)cc2n1Cc1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7966026 0.97 PLA2G2A (1.00) PLA2G2A
SCHEMBL4317828 0.92 PLA2G2A (1.00) PLA2G2A
SCHEMBL7953375 0.91 PLA2G2A (1.00) PLA2G2A
SCHEMBL7953755 0.89 PLA2G2A (1.00) PLA2G2A
SCHEMBL7963277 0.88 PLA2G2A (1.00) PLA2G2A
SCHEMBL7952631 0.87 PLA2G2A (1.00) PLA2G2A
SCHEMBL7963970 0.85 PLA2G2A (1.00) PLA2G2A
SCHEMBL8924452 0.85 PLA2G2A (0.84) PLA2G2A
SCHEMBL24353497 0.84 PLA2G2A (0.85) PLA2G2A
SCHEMBL8926191 0.84 PLA2G2A (0.79) PLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6252084-B1 THERAPY FOR SEPSIS SHOCK ELI LILLY AND COMPANY 2001-06-26 US disclosed
EP-0620215-B1 1H-indole-3-acetamide derivatives as sPLA2 inhibitors LILLY CO ELI (US) 1999-08-18 EP disclosed
EP-0620215-A1 1H-indole-3-acetamide derivatives as sPLA2 inhibitors ELI LILLY AND COMPANY (US) 1994-10-19 EP disclosed